IYER; Pravin

Patent Applications and Registrations

Patent applications and USPTO patent grants for IYER; Pravin.The latest application filed is for "cyclopropyl-amide compounds as dual lsd1/hdac inhibitors".

Company Profile

3.11.14

IYER; Pravin - Yeshwanthpur Bangalore IN
Iyer; Pravin - Ahmedabad IN
Iyer; Pravin - Bangalore IN
Iyer; Pravin - Bangaluru IN
Iyer; Pravin - Bengaluru IN
Iyer; Pravin - Mountain View CA
Iyer; Pravin - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cyclopropyl-amide Compounds As Dual Lsd1/hdac Inhibitors App 20220281815 - RAJAGOPAL; Sridharan ; et al.	2022-09-08
Cyclopropyl-amide compounds as dual LSD1/HDAC inhibitors Grant 11,352,322 - Rajagopal , et al. June 7, 2	2022-06-07
Substituted sulfoximine compounds Grant 11,236,045 - Sharma , et al. February 1, 2	2022-02-01
Heterocyclic Compounds Useful As Antibacterial Agents App 20210052597 - SHARMA; Rajiv ; et al.	2021-02-25
Cyclopropyl-amide Compounds As Dual Lsd1/hdac Inhibitors App 20200308110 - RAJAGOPAL; Sridharan ; et al.	2020-10-01
Novel Substituted Sulfoximine Compounds App 20200140382 - SHARMA; Rajiv ; et al.	2020-05-07
Triaminopyrimidine compounds useful for preventing or treating malaria Grant 9,957,253 - Hameed Peer Mohamed , et al. May 1, 2	2018-05-01
Cytochrome P450 inhibitors and their method of use Grant 9,725,436 - Blass , et al. August 8, 2	2017-08-08
Triaminopyrimidine Compounds Useful For Preventing Or Treating Malaria App 20170050951 - HAMEED PEER MOHAMED; SHAHUL ; et al.	2017-02-23
Novel Functionalized 5-(phenoxymethyl)-1,3-dioxane Analogs Exhibiting Cytochrome P450 Inhibition And Their Method Of Use App 20160244436 - Blass; Benjamin Eric ; et al.	2016-08-25
Novel Cytochrome P450 Inhibitors And Their Method Of Use App 20160221990 - Blass; Benjamin Eric ; et al.	2016-08-04
Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof Grant 8,513,425 - Iyer , et al. August 20, 2	2013-08-20
Dihydroquinone and dihydronaphthridine inhibitors of JNK Grant 8,163,906 - Abbot , et al. April 24, 2	2012-04-24
Heteroaryl Pyrrolidinyl And Piperidinyl Ketone Derivatives And Uses Thereof App 20120065225 - Iyer; Pravin ; et al.	2012-03-15
Aminopiperidinyl derivatives and uses thereof Grant 8,093,285 - Iyer , et al. January 10, 2	2012-01-10
Pyrrolidinyl and piperidinyl ketone derivatives and uses thereof Grant 8,084,623 - Iyer , et al. December 27, 2	2011-12-27
3-amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof Grant 7,803,830 - Iyer , et al. September 28, 2	2010-09-28
Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof App 20090318493 - Iyer; Pravin ; et al.	2009-12-24
Aminopiperidinyl Derivatives And Uses Thereof App 20090247568 - Iyer; Pravin ; et al.	2009-10-01
3-Amino-1-arylpropyl indoles and AZA-substituted indoles and uses thereof App 20090099236 - Iyer; Pravin ; et al.	2009-04-16
Dihydroquinone and dihydronaphthridine inhibitors of JNK App 20080287458 - Abbot; Sarah C. ; et al.	2008-11-20
3-amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof Grant 7,446,118 - Iyer , et al. November 4, 2	2008-11-04
Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof App 20080146607 - Iyer; Pravin ; et al.	2008-06-19
3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof App 20070123527 - Iyer; Pravin ; et al.	2007-05-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.